Simon Elsässer
Principal Researcher
E-mail: simon.elsasser@ki.se
Telephone: +46852481227
Visiting address: Tomtebodavägen 23A, 17165 Solna
Postal address: C2 Medicinsk biokemi och biofysik, C2 Genome biology Elsässer, 171 77 Stockholm
About me
Prof. Simon Elsässer is currently a tenured Associate Professor in Chemical and Synthetic Systems Biology at Karolinska Institutet (KI). He has developed his independent research program at KI since 2015, when he was recruited through the highly selective Science for Life Laboratory Fellows Program. He has been named a Fellow of the Ming Wai Lau Center for Reparative Medicine at KI. In 2018, he received a faculty-funded tenured Associate Professor position at KI in open competition. In 2019, he was awarded the Wallenberg Academy Fellowship and Future Research Leader Fellowship by the Swedish Foundation for Strategic Research. Next to publishing over 50 publications, he is also an scientist entrepreneur.
Selected publications
- Article: SCIENCE. 2022;376(6592):476-483Larsen BD; Benada J; Yung PYK; Bell RAV; Pappas G; Urban V; Ahlskog JK; Kuo TT; Janscak P; Megeney LA; Elsaesser SJ; Bartek J; Sorensen CS
- Article: NUCLEIC ACIDS RESEARCH. 2022;50(3):e13Lyu J; Shao R; Yung PYK; Elsasser SJ
- Article: CHEMBIOCHEM. 2021;22(22):3208-3213van Husen LS; Katsori A-M; Meineke B; Tjernberg LO; Schedin-Weiss S; Elsasser SJ
- Preprint: BIORXIV. 2021Kumar B; Navarro C; Winblad N; Schell J; Zhao C; Lanner F; Elsässer S
- Article: NATURE METHODS. 2016;13(2):158-164Elsaesser SJ; Ernst RJ; Walker OS; Chin JW
- Article: NATURE. 2015;522(7555):240-244Elsasser SJ; Noh K-M; Diaz N; Allis CD; Banaszynski LA
- Article: NATURE. 2012;491(7425):560-565Elsaesser SJ; Huang H; Lewis PW; Chin JW; Allis CD; Patel DJ
Articles
- Journal article: SCIENCE. 2025;388(6752):1225-1231Sato K; Lyu J; van den Berg J; Braat D; Cruz VM; Navarro Luzon C; Schimmel J; Esteban-Jurado C; Alemany M; Dreyer J; Hendrikx A; Mattiroli F; van Oudenaarden A; Tijsterman M; Elsasser SJ; Knipscheer P
- Article: ADVANCED SCIENCE. 2025;12(25):e2416784Niu G; Toma MA; Geara J; Bian X; Chen Y; Luo L; Wang Q; Xiao Y; Vij M; Piipponen M; Liu Z; Oasa S; Zhang L; Schlesinger D; Vegvari A; Li D; Wang A; Vukojevic V; Elsasser SJ; Sommar P; Landen XN
- Article: ISCIENCE. 2025;28(3):111884Schlesinger D; Dirks C; Navarro C; Lafranchi L; Spinner A; Raja GL; Tong GM-S; Eirich J; Martinez TF; Elsasser SJ
- Article: BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. 2024;1868(7):130619Nordahl L; Akkuratov EE; Heimgartner J; Schach K; Meineke B; Elsasser S; Wennmalm S; Brismar H
- Article: CELL REPORTS: METHODS. 2023;3(11):100626Meineke B; Heimgartner J; Caridha R; Block MF; Kimler KJ; Pires MF; Landreh M; Elsasser SJ
- Journal article: PHYSIOLOGY. 2023;38:5732603Brismar H; Edwards S; Bauer S; Meineke B; Elsasser S; Wennmalm S
- Journal article: PHYSIOLOGY. 2023;38:5732753Edwards S; Bauer S; Graef P; Meineke B; Elsasser S; Brismar H
- Article: NATURE CELL BIOLOGY. 2023;25(4):579-591Weigert R; Hetzel S; Bailly N; Haggerty C; Ilik IA; Yung PYK; Navarro C; Bolondi A; Kumar AS; Anania C; Braendl B; Meierhofer D; Lupianez DG; Mueller F-J; Aktas T; Elsaesser SJ; Kretzmer H; Smith ZD; Meissner A
- Article: METHODS IN MOLECULAR BIOLOGY. 2023;2676:169-180Meineke B; Elsässer SJ
- Article: NUCLEIC ACIDS RESEARCH. 2022;50(15):8491-8511Stolz P; Mantero AS; Tvardovskiy A; Ugur E; Wange LE; Mulholland CB; Cheng Y; Wierer M; Enard W; Schneider R; Bartke T; Leonhardt H; Elsasser SJ; Bultmann S
- Article: NATURE CELL BIOLOGY. 2022;24(6):845-857Kumar B; Navarro C; Winblad N; Schell JP; Zhao C; Weltner J; Baque-Vidal L; Salazar Mantero A; Petropoulos S; Lanner F; Elsasser SJ
- Journal article: FASEB JOURNAL. 2022;36Nordahl L; Wennmalm S; Jonsson J; Elsasser S; Akkuratov EE; Brismar H
- Article: NATURE COMMUNICATIONS. 2022;13(1):1223Morato JG; Hans F; von Zweydorf F; Feederle R; Elsasser SJ; Skodras AA; Gloeckner CJ; Buratti E; Neumann M; Kahle PJ
- Article: MOLECULAR SYSTEMS BIOLOGY. 2022;18(1):e10407Shao R; Kumar B; Lidschreiber K; Lidschreiber M; Cramer P; Elsasser SJ
- Journal article: CHEMBIOCHEM. 2021;22(22):3108van Husen LS; Katsori A; Meineke B; Tjernberg LO; Schedin‐Weiss S; Elsässer SJ
- Article: FRONTIERS IN CHEMISTRY. 2021;9:768535Meineke B; Heimgartner J; Craig AJ; Landreh M; Moodie LWK; Elsasser SJ
- Article: SCIENCE ADVANCES. 2021;7(32):eabf7561Kanellis DC; Espinoza JA; Zisi A; Sakkas E; Bartkova J; Katsori A-M; Bostrom J; Dyrskjot L; Broholm H; Altun M; Elsasser SJ; Lindstrom MS; Bartek J
- Article: NATURE COMMUNICATIONS. 2021;12(1):3695Roxhed N; Bendes A; Dale M; Mattsson C; Hanke L; Dodig-Crnkovic T; Christian M; Meineke B; Elsasser S; Andrell J; Havervall S; Thalin C; Eklund C; Dillner J; Beck O; Thomas CE; McInerney G; Hong M-G; Murrell B; Fredolini C; Schwenk JM
- Article: BIOLOGIA FUTURA. 2021;72(2):119-125Pesic M; Egamberdieva D; Kolodziejczyk B; Elsasser SJ; Neergheen VS; Kagansky A
- Article: SCIENTIFIC REPORTS. 2021;11(1):1820Alekseenko A; Barrett D; Pareja-Sanchez Y; Howard RJ; Strandback E; Ampah-Korsah H; Rovsnik U; Zuniga-Veliz S; Klenov A; Malloo J; Ye S; Liu X; Reinius B; Elsasser SJ; Nyman T; Sandh G; Yin X; Pelechano V
- Article: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 2020;142(47):20080-20087Lafranchi L; Schlesinger D; Kimler KJ; Elsasser SJ
- Article: NATURE COMMUNICATIONS. 2020;11(1):5095Navarro C; Lyu J; Katsori A-M; Caridha R; Elsasser SJ
- Article: GENES & DEVELOPMENT. 2020;34(15-16):1065-1074Bjorkman A; Johansen SL; Lin L; Schertzer M; Kanellis DC; Katsori A-M; Christensen ST; Luo Y; Andersen JS; Elsasser SJ; Londono-Vallejo A; Bartek J; Schou KB
- Article: CELL REPORTS. 2020;31(12):107811Meineke B; Heimgertner J; Eirich J; Landreh M; Elsasser SJ
- Article: JOURNAL OF ALZHEIMERS DISEASE. 2019;72(2):537-548van Husen LS; Schedin-Weiss S; Minh NT; Kazmi MA; Winblad B; Sakmar TP; Elsaesser SJ; Tjernberg LO
- Article: CELL REPORTS. 2019;28(12):3274-3284.e5Kumar B; Elsasser SJ
- Article: ACS CHEMICAL BIOLOGY. 2018;13(11):3087-3096Meineke B; Heimgartner J; Lafranchi L; Elsasser SJ
- Article: METHODS IN MOLECULAR BIOLOGY. 2018;1728:237-245Elsässer SJ
- Article: MOLECULAR SYSTEMS BIOLOGY. 2017;13(8):938Lee S; Zhang C; Liu Z; Klevstig M; Mukhopadhyay B; Bergentall M; Cinar R; Stahlman M; Sikanic N; Park JK; Deshmukh S; Harzandi AM; Kuijpers T; Grotli M; Elsasser SJ; Piening BD; Snyder M; Smith U; Nielsen J; Backhed F; Kunos G; Uhlen M; Boren J; Mardinoglu A
- Article: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 2016;138(3):718-721Walker OS; Elsaesser SJ; Mahesh M; Bachman M; Balasubramanian S; Chin JW
- Article: NEURON. 2015;87(1):77-94Maze I; Wenderski W; Noh K-M; Bagot RC; Tzavaras N; Purushothaman I; Elsaesser SJ; Guo Y; Ionete C; Hurd YL; Tamminga CA; Halene T; Farrelly L; Soshnev AA; Wen D; Rafii S; Birtwistle MR; Akbarian S; Buchholz BA; Blitzer RD; Nestler EJ; Yuan Z-F; Garcia BA; Shen L; Molina H; Allis CD
- Article: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 2014;136(44):15577-15583Schmied WH; Elsaesser SJ; Uttamapinant C; Chin JW
- Article: NATURE BIOTECHNOLOGY. 2014;32(5):465-472Elliott TS; Townsley FM; Bianco A; Ernst RJ; Sachdeva A; Elsaesser SJ; Davis L; Lang K; Pisa R; Greiss S; Lilley KS; Chin JW
- Article: NUCLEIC ACIDS RESEARCH. 2014;42(7):4318-4331DeNizio JE; Elsaesser SJ; Black BE
- Article: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 2014;136(6):2240-2243Nguyen DP; Mahesh M; Elsaesser SJ; Hancock SM; Uttamapinant C; Chin JW
- Article: CELL. 2013;155(1):107-120Banaszynski LA; Wen D; Dewell S; Whitcomb SJ; Lin M; Diaz N; Elsaesser SJ; Chapgier A; Goldberg AD; Canaani E; Rafii S; Zheng D; Allis CD
- Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2013;1819(3-4):211-221Elsaesser SJ; D'Arcy S
- Article: NATURE STRUCTURAL & MOLECULAR BIOLOGY. 2012;19(8):819-823Liokatis S; Stuetzer A; Elsaesser SJ; Theillet F-X; Klingberg R; van Rossum B; Schwarzer D; Allis CD; Fischle W; Selenko P
- Article: BIOCHEMICAL PHARMACOLOGY. 2011;81(1):32-42Rudner J; Elsaesser SJ; Jendrossek V; Huber SM
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010;107(32):14075-14080Lewis PW; Elsaesser SJ; Noh K-M; Stadler SC; Allis CD
- Article: CELL. 2010;140(5):678-691Goldberg AD; Banaszynski LA; Noh K-M; Lewis PW; Elsaesser SJ; Stadler S; Dewell S; Law M; Guo X; Li X; Wen D; Chapgier A; DeKelver RC; Miller JC; Lee Y-L; Boydston EA; Holmes MC; Gregory PD; Greally JM; Rafii S; Yang C; Scambler PJ; Garrick D; Gibbons RJ; Higgs DR; Cristea IM; Urnov FD; Zheng D; Allis CD
- Article: COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY. 2010;75:27-34Elsaesser SJ; Allis CD
- Article: BIOCHEMICAL PHARMACOLOGY. 2010;79(1):10-20Rudner J; Elsaesser SJ; Mueller A-C; Belka C; Jendrossek V
- Article: BIOCHEMICAL PHARMACOLOGY. 2008;76(9):1082-1096Mueller A-C; Handrick R; Elsaesser SJ; Rudner J; Henke G; Ganswindt U; Belka C; Jendrossek V
- Article: NATURE STRUCTURAL & MOLECULAR BIOLOGY. 2008;15(3):321-329Selenko P; Frueh DP; Elsaesser SJ; Haas W; Gygi SP; Wagner G
- Show more
All other publications
- Preprint: BIORXIV. 2025Lyu J; Hetey S; Castelo-Branco G; Bartosovic M; Elsässer SJ
- Preprint: BIORXIV. 2024Vandeuren AL; O’Dare K; Wilson RHC; van Eijk P; Julio LR; MacLeod SG; Chee E; Salpukas A; Kriz EM; Lantz GA; Gordon S; Elsässer SJ; Reed SH; Day TA
- Preprint: BIORXIV. 2024Lafranchi L; Spinner A; Hornisch M; Schlesinger D; Luzon CN; Brinkenstråhle L; Shao R; Piazza I; Elsässer SJ
- Review: NATURE PROTOCOLS. 2024;20(3):779-809Kumar B; Navarro C; Yung PYK; Lyu J; Mantero AS; Katsori A-M; Schwaemmle H; Martin M; Elsaesser SJ
- Conference publication: FEBS OPEN BIO. 2024;14:17Kumar B; Navarro C; Elsasser S
- Preprint: BIORXIV. 2023Schlesinger D; Dirks C; Luzon CN; Lafranchi L; Eirich J; Elsässer S
- Preprint: BIORXIV. 2023Meineke B; Heimgärtner J; Caridha R; Block M; Kimler K; Pires M; Landreh M; Elsässer S
- Preprint: BIORXIV. 2022Navarro C; Martin M; Elsässer S
- Review: FEBS JOURNAL. 2022;289(1):53-74Schlesinger D; Elsasser SJ
- Preprint: BIORXIV. 2021van Husen L; Katsori A-M; Meineke B; Tjernberg L; Schedin-Weiss S; Elsässer S
- Preprint: BIORXIV. 2021Shao R; Kumar B; Lidschreiber K; Lidschreiber M; Cramer P; Elsässer S
- Preprint: BIORXIV. 2021Lyu J; Shao R; Elsässer S
- Preprint: MEDRXIV. 2020Alekseenko A; Barrett D; Pareja-Sanchez Y; J Howard R; Strandback E; Ampah-Korsah H; Rovšnik U; Zuniga-Veliz S; Klenov A; Malloo J; Ye S; Liu X; Reinius B; Elsässer S; Nyman T; Sandh G; Yin X; Pelechano V
- Preprint: MEDRXIV. 2020Roxhed N; Bendes A; Dale M; Mattsson C; Hanke L; Dodig-Crnkovic T; Christian M; Meineke B; Elsässer S; Andréll J; Havervall S; Thålin C; Eklund C; Dillner J; Beck O; Thomas C; McInerney G; Hong M-G; Murrell B; Fredolini C; Schwenk J
- Preprint: BIORXIV. 2020Morato JG; Hans F; von Zweydorf F; Feederle R; Elsässer S; Skodras A; Gloeckner CJ; Buratti E; Neumann M; Kahle P
- Preprint: BIORXIV. 2020Navarro C; Elsässer S
- Review: DEVELOPMENT. 2019;146(19):dev178962Drinnenberg IA; Berger F; Elsasser SJ; Andersen PR; Ausio J; Bickmore WA; Blackwell AR; Erwin DH; Gahan JM; Gaut BS; Harvey ZH; Henikoff S; Kao JY; Kurdistani SK; Lemos B; Levine MT; Luger K; Malik HS; Martin-Duran JM; Peichel CL; Renfree MB; Rutowicz K; Sarkies P; Schmitz RJ; Technau U; Thornton JW; Warnecke T; Wolfe KH
- Preprint: BIORXIV. 2019Kumar B; Elsässer S
- Preprint: BIORXIV. 2018Meineke B; Heimgärtner J; Lafranchi L; Elsässer S
- Review: CURRENT OPINION IN CHEMICAL BIOLOGY. 2017;41:36-42Yung PYK; Elsasser SJ
- Editorial comment: JOURNAL OF GLOBAL HEALTH. 2017;7(2):020304Neergheen-Bhujun V; Awan AT; Baran Y; Bunnefeld N; Chan K; Edison Dela Cruz T; Egamberdieva D; Elsasser S; Johnson M-VV; Komai S; Konevega AL; Malone JH; Mason P; Nguon R; Piper R; Shrestha UB; Pesic M; Kagansky A
- Letter: NATURE. 2017;548(7665):E7-E9Elsasser SJ; Noh K-M; Diaz N; Allis CD; Banaszynski LA
- Editorial comment: TRENDS IN BIOCHEMICAL SCIENCES. 2013;38(7):333-336Elsaesser SJ
- Meeting abstract: BIOPHYSICAL JOURNAL. 2013;104(2):29a-30aDeNizio JE; Elsaesser SJ; Allis CD; Black BE
- Editorial comment: SCIENCE. 2011;331(6021):1145-1146Elsaesser SJ; Allis CD; Lewis PW
- Review: CURRENT OPINION IN GENETICS & DEVELOPMENT. 2010;20(2):110-117Elsaesser SJ; Goldberg AD; Allis CD
- Conference publication: STRAHLENTHERAPIE UND ONKOLOGIE. 2008;184:15-16Rudner J; Elsaesser S; Mueller A-C; Belka C; Jendrossek V
- Show more
Grants
- Swedish Research Council1 January 2024 - 31 December 2028The first lineage choice in human embryo development extra- and embryonic cell fates. Extraembryonic trophectoderm (TE) gives rise to placental tissues while the inner cell mass (ICM) progresses via the epiblast stage to form the fetus. The restriction of ICM cells to embryonic lineage capacity is crucial for ordered embryonic development, and concomitant development of extraembryonic support tissue from TE is crucial for survival of the embryo. These earliest steps are remarkably inefficient in humans: it is estimated that only one in three conceptions progress to live birth, with an early time window before and after implantation being the most crucial stages for a successful pregnancy. The aim of this project is to elucidate the mechanisms of the first cell fate decision and subsequent lineage determination by employing in vitro preimplantation models based on naïve human embryonic stem cells and 3D blastoids. The project will rely on quantitative epigenome profiling technology, functional perturbations, live cell imaging, and single-cell multimodal readouts to capture complex regulatory networks at play during early human development. We will more broadly elucidate how chromatin makeup dynamically changes as a function of the cell cycle and how cells integrate internal and external information to make cell fate decisions. Our research will further technology for dissecting complex developmental programs and provide insights into early human development and fertility.
- Swedish Research Council1 December 2023 - 30 November 2028Understanding fundamental principles that regulate the early human embryo has clinical value for reproductive technologies, congenital disease, and regenerative medicine. My lab and others have begun to uncover the molecular mechanisms controlling the first week of development but following implantation, we have very poor understanding beyond historic histological characterisations. We have learned a lot from the mouse, but human post-implantation development is very distinct from mouse. One example, following implantation a primate specific cell type fills the blastocoel cavity prior to gastrulation, the extra embryonic mesenchyme. This cell type is completely lacking in the mouse.New opportunities to study post-implantation development has emerged through extended blastocyst cultures and stem cell-based embryo models. In this project we will build a comprehensive spatial single cell transcriptional atlas of implantation, describing the cell types and the genes that control them. This resource will be critical to validate blastoids and post-implantation embryo models. Functionally we will use the transcriptional information and validated embryo models, together with genome editing to dissect regulators of the implantation event and lineage specification of the extra embryonic mesenchyme and amnion. Lastly, we will extend our recent studies of the epigenetic control through Polycomb Repressive Complex 2, histone deacetylation and X-chromosome inactivation in female embryos.
- Swedish Cancer Society1 January 2023Short open reading frames, which encode small proteins or peptides, outnumber canonical open reading frames in the human genome by an order of magnitude, but extremely little is known about their function and disease relevance. This is because it was traditionally thought that smaller than normal proteins could have no function. But now our research and that of others shows that there is a huge, hitherto unknown, functional repertoire within short open reading frames. We search for small proteins and peptides that help cancer cells avoid chemotherapy. We are working with cancer cell lines for our first investigations. When we identify small proteins that make cancer cells grow better despite treatment, we generate molecular tools that can be used to look for these proteins in primary tumor samples and patients. We are evaluating whether the small protein can be targeted to a molecule, which can be turned into a chemotherapy. We hope our research will help cure cancers that currently elude the best treatments. We believe that identifying new drug targets is the key to preventing tumors from becoming resistant to chemotherapy.
- European Research Council1 January 2021 - 30 June 2022
- Swedish Research Council1 January 2021 - 31 December 2024
- Swedish Research Council1 January 2018 - 31 December 2021
- Studies of epigenetic mechanisms in the pancreas and brain tumorsSwedish Cancer Society1 January 2018The human genome can be described as an entire library of books, in which the letters of DNA form genes or chapters. Just as errors in the genetic language itself can cause diseases such as developmental disorders and cancer, diseases can be caused by reading from the wrong pages in the book. The role of chromate is to package the genome into available and unavailable domains, and thus ensure the overall organization of the genome. If this process fails, there is a risk of morbid changes in the genome, changes that can cause cancer and aging. Histone proteins package the double-stranded DNA molecules, which make up the human genome, into a very well-condensed state of the cell nucleus. The central role of the histones in the packaging process means that we believe that they are the key to regulating genetic information and constitute the actual molecular basis for indexing the genome with epigenetic information. Clinical studies have shown that several proteins that assist in the packaging of DNA are mutated in pancreatic tumors and brain tumors. We want to find out what these proteins (ATRX and DAXX) do at the molecular level, as well as their importance in curbing the development of tumors. Our research on the mechanism of epigenetic heritage will help us understand how abnormal epigenetic changes cause disease, for example, how tumor suppressor genes - important guardians of the genome - turn off when cancer occurs. We hope to find information at a molecular level to develop therapeutic strategies to correct such epigenetic mistakes.
- Knut and Alice Wallenberg Foundation1 January 2017 - 1 January 2022
- European Research Council1 January 2017 - 30 June 2022
- Studies of epigenetic mechanisms in the pancreas and brain tumorsSwedish Cancer Society1 January 2017The human genome can be described as an entire library of books, in which the letters of DNA form genes or chapters. Just as errors in the genetic language itself can cause diseases such as developmental disorders and cancer, diseases can be caused by reading from the wrong pages in the book. The role of chromate is to package the genome into available and unavailable domains, and thus ensure the overall organization of the genome. If this process fails, there is a risk of morbid changes in the genome, changes that can cause cancer and aging. Histone proteins package the double-stranded DNA molecules, which make up the human genome, into a very well-condensed state of the cell nucleus. The central role of the histones in the packaging process means that we believe that they are the key to regulating genetic information and constitute the actual molecular basis for indexing the genome with epigenetic information. Clinical studies have shown that several proteins that assist in the packaging of DNA are mutated in pancreatic tumors and brain tumors. We want to find out what these proteins (ATRX and DAXX) do at the molecular level, as well as their importance in curbing the development of tumors. Our research on the mechanism of epigenetic heritage will help us understand how abnormal epigenetic changes cause disease, for example, how tumor suppressor genes - important guardians of the genome - turn off when cancer occurs. We hope to find information at a molecular level to develop therapeutic strategies to correct such epigenetic mistakes.
- Swedish Research Council1 January 2016 - 31 December 2019
- Studies of epigenetic mechanisms in the pancreas and brain tumorsSwedish Cancer Society1 January 2016The human genome can be described as an entire library of books, in which the letters of DNA form genes or chapters. Just as errors in the genetic language itself can cause diseases such as developmental disorders and cancer, diseases can be caused by reading from the wrong pages in the book. The role of chromate is to package the genome into available and unavailable domains, and thus ensure the overall organization of the genome. If this process fails, there is a risk of morbid changes in the genome, changes that can cause cancer and aging. Histone proteins package the double-stranded DNA molecules, which make up the human genome, into a very well-condensed state of the cell nucleus. The central role of the histones in the packaging process means that we believe that they are the key to regulating genetic information and constitute the actual molecular basis for indexing the genome with epigenetic information. Clinical studies have shown that several proteins that assist in the packaging of DNA are mutated in pancreatic tumors and brain tumors. We want to find out what these proteins (ATRX and DAXX) do at the molecular level, as well as their importance in curbing the development of tumors. Our research on the mechanism of epigenetic heritage will help us understand how abnormal epigenetic changes cause disease, for example, how tumor suppressor genes - important guardians of the genome - turn off when cancer occurs. We hope to find information at a molecular level to develop therapeutic strategies to correct such epigenetic mistakes.